August 7, 2026

Day 108

One Good Trade
Regime: GREEN

GREEN Full allocation — 5 picks deployed.

The Picks

Ticker Scan Price Gap % RVOL Catalyst ML Hold Prob ML Expected
GMAB $31.35 7.14 36.69 Earnings: Genmab raised FY2026 sales guidance to $4.325B-$4.525B, above the $4.355B consensus estimate, indicating stronger-than-expected business performance. — —
ZTS $77.57 4.27 34.91 Other: Multiple catalysts including softer pet health demand headwinds, analyst downgrade to Market Perform, and CFO/COO leadership appointment effective August 17. — —
SPCX $115.10 6.31 34.58 Analyst: SpaceX analyst upgraded to bullish stance with top 5 upgrades for the trading day, providing positive sentiment on the company's growth trajectory. — —
FSK $11.91 7.88 26.89 Earnings: FS KKR Capital beat Q2 earnings and revenue estimates with EPS of $0.43 vs $0.42 expected and sales of $290M vs $286.4M expected, while Truist raised price target to $12. — —
DEO $97.01 9.70 36.65 Earnings: Diageo reported FY results with guidance for low-single-digit organic net sales CAGR through FY29 and announced aggressive cost reduction targeting 10.5% overhead ratio by September. — —

The Results

Ticker Entry Entry Time Exit Exit Time Method P/L % Catalyst
GMAB $31.52 $31.09 10:32 AM VoV Spike $-39.99 -1.36 Earnings: Genmab raised FY2026 sales guidance to $4.325B-$4.525B, above the $4.355B consensus estimate, indicating stronger-than-expected business performance.
ZTS $76.41 $72.38 Limit Close $-515.31 -5.27 Other: Multiple catalysts including softer pet health demand headwinds, analyst downgrade to Market Perform, and CFO/COO leadership appointment effective August 17.
SPCX $118.37 $130.68 3:20 PM Limit Close $1,058.42 10.40 Analyst: SpaceX analyst upgraded to bullish stance with top 5 upgrades for the trading day, providing positive sentiment on the company's growth trajectory.
FSK $11.95 $12.53 3:20 PM Limit Close $485.11 4.84 Earnings: FS KKR Capital beat Q2 earnings and revenue estimates with EPS of $0.43 vs $0.42 expected and sales of $290M vs $286.4M expected, while Truist raised price target to $12.
DEO $96.20 $96.53 Limit Close $33.50 0.34 Earnings: Diageo reported FY results with guidance for low-single-digit organic net sales CAGR through FY29 and announced aggressive cost reduction targeting 10.5% overhead ratio by September.

Shadow Results

Ticker Shadow Entry Shadow Exit Exit Time Method Shadow P/L % Result Catalyst
GMAB $31.52 $31.09 10:32 AM VoV Spike $-39.99 -1.36 LOSS Earnings: Genmab raised FY2026 sales guidance to $4.325B-$4.525B, above the $4.355B consensus estimate, indicating stronger-than-expected business performance.
ZTS $76.41 $72.38 Limit Close $-515.31 -5.27 LOSS Other: Multiple catalysts including softer pet health demand headwinds, analyst downgrade to Market Perform, and CFO/COO leadership appointment effective August 17.
SPCX $118.37 $130.68 3:20 PM Limit Close $1,058.42 10.40 WIN Analyst: SpaceX analyst upgraded to bullish stance with top 5 upgrades for the trading day, providing positive sentiment on the company's growth trajectory.
FSK $11.95 $12.53 3:20 PM Limit Close $485.11 4.84 WIN Earnings: FS KKR Capital beat Q2 earnings and revenue estimates with EPS of $0.43 vs $0.42 expected and sales of $290M vs $286.4M expected, while Truist raised price target to $12.
DEO $96.20 $96.53 Limit Close $33.50 0.34 WIN Earnings: Diageo reported FY results with guidance for low-single-digit organic net sales CAGR through FY29 and announced aggressive cost reduction targeting 10.5% overhead ratio by September.

Things to Explore

Interested in our research, validation methodology, and trading system?

Get in Touch

Work With Diana

Need a context architect to scaffold your AI agents and facilitate structured learning?

Visit goddev.ai

This post is part of a series documenting MorningEdge's development in real time. The knowledge base contains 0 books, papers, and lab reports totaling 0+ searchable chunks. The trading system described is paper trading only — no real capital is at risk.